Société Syros Pharmaceuticals, Inc.
Actions
SYRS
US87184Q2066
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
6,14 USD | +2,33 % |
|
+18,53 % | -21,18 % |
25/06 | Transcript : Syros Pharmaceuticals, Inc. - Special Call | |
05/06 | Transcript : Syros Pharmaceuticals, Inc. - Shareholder/Analyst Call |
Métier
Nombre d'employés: 68
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Gene Control Medicines
100,0
%
| 15 | 100,0 % | 10 | 100,0 % | -33,23 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 15 | 100,0 % | 10 | 100,0 % | -33,23 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Conley Chee
CEO | Chief Executive Officer | 54 | 27/09/21 |
Nancy Simonian
CEO | Chief Executive Officer | 63 | 01/11/12 |
Jason Haas
DFI | Director of Finance/CFO | 56 | 12/10/21 |
David Roth
CTO | Chief Tech/Sci/R&D Officer | 61 | 07/12/15 |
Gerald Quirk
ADM | Chief Administrative Officer | 56 | 01/09/16 |
Karen Hunady
IRC | Investor Relations Contact | - | 01/10/22 |
Lisa Roberts
HRO | Human Resources Officer | - | 01/01/12 |
Kristin Stephens
PRN | Corporate Officer/Principal | 51 | 01/03/15 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 56 | 12/06/17 | |
Tim Tyson
BRD | Director/Board Member | 71 | 16/09/22 |
Marsha Fanucci
BRD | Director/Board Member | 70 | 19/10/15 |
Deborah Dunsire
BRD | Director/Board Member | 61 | 09/09/21 |
Peter Wirth
CHM | Chairman | 73 | 30/01/17 |
Nancy Simonian
CEO | Chief Executive Officer | 63 | 01/11/12 |
Richard Young
FOU | Founder | 70 | 09/11/11 |
S. Gail Eckhardt
BRD | Director/Board Member | 66 | 08/09/20 |
Andrew Oh
BRD | Director/Board Member | 53 | 16/09/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 26 728 337 | 26 343 113 ( 98,56 %) | 0 | 98,56 % |
Coordonnées société
Syros Pharmaceuticals, Inc.
35 CambridgePark Drive 4th floor
02140-2325, Cambridge
+617 744 1340
http://www.syros.com![Adresse Syros Pharmaceuticals, Inc.(SYRS)](https://cdn.zonebourse.com/static/address/29688130.png)
Secteur
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-21,18 % | 164 M | |
+22,15 % | 46,56 Md | |
+45,09 % | 41,67 Md | |
-2,37 % | 41,16 Md | |
+33,84 % | 32,4 Md | |
-6,35 % | 28,1 Md | |
+20,42 % | 28,18 Md | |
+48,83 % | 14,52 Md | |
+45,00 % | 13,74 Md | |
+0,06 % | 12,17 Md |
- Bourse
- Actions
- Action SYRS
- Société Syros Pharmaceuticals, Inc.